We are live on ! Find out more
HURA icon

TuHURA Biosciences
HURA

8 hedge funds and large institutions have $164K invested in TuHURA Biosciences in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.56% less ownership

Funds ownership: 2.99% → 2.42% (-0.56%)

11% less funds holding

Funds holding: 9 → 8 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less capital inflows, than outflows

Capital inflows: $11.5K | Capital outflows: $46.1K

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$9.7K
2
JP Morgan Chase
JP Morgan Chase
New York
+$1.82K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$39.2K
2
UBS Group
UBS Group
Switzerland
-$6.71K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$107

HURA Hedge Fund Activity: Q2 2023 in Review

8 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2023, worth a combined $164K — down 9.5% from $181K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of HURA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $9.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $39.2K sold.

  • 8 institutional investors held TuHURA Biosciences (HURA) as of Q2 2023, down from 9 in Q1 2023.
  • Funds reported $164K of TuHURA Biosciences stock for Q2 2023, down 9.5% quarter-over-quarter.
  • 1 fund opened new TuHURA Biosciences positions in Q2 2023 and 2 closed out, a net change of -1 holder.
  • The largest TuHURA Biosciences buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $9.7K added.
  • The largest TuHURA Biosciences seller in Q2 2023 was Susquehanna International Group, an estimated $39.2K sold.

Based on aggregated 13F filings for Q2 2023.